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Abstract
Background: Overweight is reported as a side effect of SDR. The aims were to study the development of weight, 
height and body mass index (BMI) during five years after SDR.
Methods: This prospective, longitudinal and practice-based study included all 56 children with CP spastic diplegia 
undergoing SDR from the start in March 1993 to April 2003 in our hospital. The preoperative Gross Motor Function 
Classification System (GMFCS) levels were I-II in 17, III in 15, IV-V in 24 children. Median age at SDR was 4.3 years (range 
2.4-7.4 years). Weight and height/recumbent length were measured. Swedish growth charts for typically developing 
children generated weight, height and BMI z-scores for age and gender.
Results: The preoperative median z-scores were for height -1.92 and for body mass index (BMI) -0.22. Five years later, 
the median BMI z-score was increased by + 0.57 (p < 0.05). The occurrence of thinness (BMI < -2 SD) was decreased 
(n.s.) and obesity (BMI > + 2 SD) increased (p < 0.05). Baseline BMI and age at the start of follow-up influenced the BMI 
change during the five years (p < 0.001 and p < 0.05 respectively).
The individual growth was highly variable, but a tendency towards increasing stunting with age was seen in severe
gross motor dysfunction (GMFCS levels IV-V) and the opposite, a slight catch-up of height in children with walking
ability (GMFCS levels I-III).
Conclusions: These are the first available subtype- and GMFCS-specific longitudinal growth data for children with CP 
spastic diplegia. Their growth potential according to these data should be regarded as a minimum, as some children 
were undernourished. It is unknown whether the spasticity reduction through SDR increased the weight gain velocity, 
or if the relative weight increase was part of the general "obesity epidemic".
For some children the weight increase was highly desirable. In others, it resulted in overweight and obesity with risk of 
negative health effects. Weight and height should be monitored to enable early prevention of weight aberrations also 
causing problems with mobility, activity and participation.
Background
Children with cerebral palsy (CP) are generally short and
many, especially non-ambulating children with CP, are
severely underweight and stunted. It is unclear how much
cerebral palsy per se brings leanness and short stature [1-
3]. Other factors contribute. Dysphagia and other feeding
problems with malnutrition are probably the most impor-
tant obstacle to exploiting the intrinsic growth potential
in many children and adolescents with CP [4-6].
Energy expenditure in spastic CP is not well under-
stood. Adaptation to low food intake, altered regulation
of basal metabolism, reduced lean body mass, and
decreased mobility are suggested to counterbalance the
energy costs of spasticity [7].
On the other hand, increased weight gain velocity after
reduction of muscle tone by means of intrathechal
baclofen (ITB) is reported in the literature [8-12]. Roberts
and co-workers observed a similar phenomenon in chil-
dren whose spasticity was reduced by selective dorsal
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rhizotomy (SDR) [13]. Weight centiles were crossed in an
upward direction as opposed to height, which may open
on to obesity in the long run [14]. The weight gains post
ITB and SDR happen without any known change in the
eating habits of the children. Hypothetically it is due to
decreased caloric demands because of the decreased
muscle tone.
R e f e r e n c e  g r o w t h  c u r v e s  f o r  c h i l d r e n  w i t h  C P  h a v e
been developed [3,7,15], but cannot be used as a standard
reference, since many of the included children had differ-
ent degrees of chronic malnutrition. The growth develop-
ment in adequately nourished and otherwise healthy
children with CP remains to be established [3]. In addi-
tion, growth profiles differ between gross motor function
levels [16] and are conceivable for the different CP sub-
types.
SDR is a safe and effective method of reducing spastic-
ity permanently without major negative side effects in
children with CP spastic diplegia. In combination with
physiotherapy SDR provides lasting functional benefits in
carefully selected and systematically monitored young
children. Improvements over time during a five-year fol-
low-up period are found [17].
As the goal of treatment is to improve activities and
participation, a long-term follow-up of all the children is
necessary to answer crucial questions about their func-
tion as adolescents and young adults. As a part of this,
growth data collected during the prospective follow-up of
all SDR-operated children with spastic diplegia in Lund
were used to explore their pattern of growth. The aims of
this study were
• to describe the growth during five years of SDR-
operated children with CP spastic diplegia at different 
GMFCS levels
• to compare weight, height and body mass index 
(BMI) before and five years after SDR
• to disclose any overweight and obesity, a suspected 
SDR side effect, that could compromise future func-
tion and health.
Methods
Design
The study is part of a structured follow-up scheme in
clinical practice to develop and secure the efficacy of
health care interventions; a prospective long-term study
of a consecutive, complete 10-year series of SDR-oper-
ated children with CP spastic diplegia.
Patients
All children with the CP type spastic diplegia undergoing
SDR at the University Hospital in Lund from the start in
March 1993 to April 2003 were included. Only children
with definite cerebral palsy according to common defini-
tions [18] were selected. The predominant neurological
sign was spasticity and the lower extremities were more
involved than the upper [19]. The level of gross motor
function was classified pre-operatively according to the
Gross Motor Function Classification System (GMFCS)
[20].
During the study period 56 children with spastic diple-
gia were operated on with SDR. Background data are pre-
sented in Table 1. Five children with functional level
GMFCS I and one child with GMFCS V are presented
together with children with GMFCS levels II and IV. The
three children with missing weight and/or height mea-
surements pre-operatively are presented in Table 2. In
one child, with functional level GMFCS III, the pre-oper-
ative measurements used were recorded at 1.3 years of
age, and the operation was performed at 3.9 years of age.
All other pre-operative measurements were performed
one or a few days before the SDR operation. The follow-
up visits five years after the operation were performed as
scheduled within ± 2 months.
Measurements
All children were followed for five years and were exam-
ined by the same team (two physiotherapists (PTs) and
two neuropaediatricians) pre-operatively and then after
6, 12, 18 months, three and five years. On all occasions
the weight and height were measured in a standardized
way, after training, by the same persons (EN or ALJ),
when necessary together with one of the others or the
child's own PT. The same equipment was used during the
first nine years; different equipment was used after the
clinic moved to the new children's hospital.
A calibrated standard hospital balance was used. Small
children without standing ability were weighed when
h e l d  i n  t h e  a r m s  o f  a n  a d u l t .  O l d e r  c h i l d r e n  w i t h o u t
standing ability were weighed in a sit balance. Children
wore only thin underwear or the weight of diapers or
light clothes was subtracted.
A standard stadiometer was used for height measure-
ments. In children without standing ability recumbent
length was measured on a gym mat, using a measuring-
tape. Joint range of motion was measured on all occasions
and spine deformities were recorded. As reported else-
where, contractures and spinal deformities were rare and,
if present, mild [17].
Weight and height were inscribed into computerized
Swedish growth charts, in which Body Mass Index (BMI)
and z-scores (standard deviations, SD) for age and gender
were automatically calculated [21-23]. BMI is weight
(kg)/height (m) 2. BMI > + 1 SD was classified as over-
weight, BMI > + 2 SD as obesity, < -2 SD as thinness and <
-3 SD as severe thinness according to the WHO child
growth standards [24].Westbom et al. BMC Neurology 2010, 10:57
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Statistics
Statistical analysis was done by ordinary paired t-tests
and multiple linear regression using the statistical pro-
gramming language R [25]. BMI five years after operation
was chosen as the primary end-point and correction was
made for age at operation and GMFCS level.
McNemar test was used for comparison between pre-
and five years postoperative overweight, obesity and thin-
ness.
Ethics
According to section 31 of the Swedish Health Act clini-
cians are obliged to secure and develop the quality and
document efficacy of care, especially when introducing
new treatment methods, such as SDR in 1993 [26].
Approval from an institutional review board is not
required for this type of research, but patients and all data
must be and are handled according to the Helsinki Decla-
ration. Informed consent was obtained from the partici-
pating families.
Results
Patients
A large proportion (43%) of the children in our study had
preoperative gross motor function classified at GMFCS
levels IV-V, 27% at level III and 30% at levels I-II. Twice as
many boys as girls were SDR-operated (37:19). The
male:female ratio was 1:1 at GMFCS I-II, but increased
with increasing motor disability. The majority (48/56
children) were born pre-term. Median weight z-score at
birth for gender and gestational age was -0.75 compared
to the median weight z-score -1.33 at the SDR-operation
in the pre-school years. The total age range at operation
was 2.4 to 7.4 years, median age was 4.3 years (Table 1).
The five children operated before three years of age had
their gross motor function classified as GMFCS level IV
and all five children operated after their 6th birthday as
levels GMFCS II-III. The three children with missing pre-
operative data had a similar background to the rest of the
operated children (Table 2).
Weight, height and BMI
Complete anthropometric measurements, according to
the SDR follow-up scheme including the preoperative
and five-year postoperative visit, were recorded on 318
(95%) out of the planned 336 occasions. All 56 children
had completely recorded measurements 18 months post
SDR (Tables 1 &2).
Of all 56 children six (11%) had BMI z-scores below -2
(thinness) and two (4%) higher than +2 (obesity) preoper-
atively. In addition one child with missing preoperative
height/BMI weighed + 2.3 SD preoperatively (Table 2). As
a group, children at GMFCS level III were heavier but not
Table 1: Patients - preoperative characteristics
GMFCS I-II GMFCS III GMFCS IV-V TOTAL
n = 17 (30%) n = 15 (27%) n = 24 (43%) n = 56
Boys 9 11 17 37
Girls 8 4 7 19
Ratio boys:girls 1.1:1 2.75:1 3.4:1 1.95:1
Gestational age (GA):
completed weeks
>  2 6 1034
26-27 2 0 1 3
28-31 6 10 14 30
32-36 4 4 2 10
37-42 4 1 3 8
>  4 2 0000
Premature. GA not specified 0 0 1 1
Birth weight z-score median -0.55 (-1.38 to 0.51; -0.75 (-1.64 to -0.58; -0.48 (-1.08 to 0.47; -0.75 (-1.52 to 0.40;
(interquartile; range) -3.35 to 2.86) -4.14 to 0.43) * -2.73 to 5.60)** -4.14 to 5.6)
Age at SDR operation, years: 
Median (interquartile: range)
4.3 (3.9 to 5.2; 5.1 (3.9 to 5.8; 3.9 (3.3 to 4.8; 4.3 (3.4 to 5.2;
3.3 to 7.4) 3.0 to 6.6) 2.4 to 5.9) 2.4 to 7.4)
* two missing, ** three missingWestbom et al. BMC Neurology 2010, 10:57
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less stunted than the other groups, resulting in a higher
median BMI z-score at GMFCS level III (Table 3).
In the total group the preoperative median z-scores
were -1.33 for weight, -1.92 for height and -0.22 for BMI.
During the five-year follow-up the weight z-score median
increase was 0.43, the height z-score was less changed
(0.04) and the BMI score median increased by 0.57. All
groups did not increase their BMI during the follow-up.
The median increase in BMI z-score was highest (0.81) in
children with milder gross motor functional limitations,
GMFCS levels I-II. In the children with the highest BMI,
GMFCS level III, the BMI z-score showed a small median
decrease (-0.15) from pre- to five years postoperatively
(Table 3).
The median BMI z-score increase between the SDR
operation and the follow-up five years later was 0.57
(interquartile range -0.32 to 1.79). The difference
between pre- and five-year follow-up BMI z-scores was
statistically significant (p < 0.01). The baseline, pre-oper-
ative BMI showed a statistically significant effect on the
BMI change during five years (p < 0.001), as did age at the
start of the follow-up (p < 0.05). GMFCS level and gender
did not exhibit a significant effect on the BMI z-score
change during the five-year follow-up.
Under- and overweight
Five of six children with BMI z-score < -2.0 before SDR
operation were within typical limits (± 2.0 SD) five years
later, while one of the children with typical BMI preoper-
atively had acquired severe thinness (BMI < -3.0 SD). The
two children with preoperative BMI > 2.0 SD were still
obese five years later. Six children had acquired obesity
defined as BMI z-score > 2.0. Of the eight children with
obesity after five years, three had BMI > 2.5 SD and pre-
operative BMI z-scores of -0.05, 1.90 and 2.61.
Of the three children without complete preoperative
measurements, one had BMI z-score > 2.00 at the five-
year follow-up and one was severely underweight and
stunted at the last contact 18 months postoperatively
(Table 2).
In total the number of children with BMI < -2 SD (thin-
ness) decreased and the number with BMI z-score > + 1.0
(overweight) was higher after the five-year follow-up, but
these changes did not reach statistical significance. Obe-
sity, defined as BMI < 2.0 SD increased (p < 0.05).
Age-specific weight, height and BMI development
Figures 1,2,3,4,5,6,7,8 &9 show mean weight, height and
BMI z-scores for all 56 children with CP diplegia in the
different gross motor functional levels at different age
during the follow-up, together with individual plots. The
children were between 7.4 and 12.4 years of age at the lat-
est measurement. Each child is represented with the same
colour in the weight, height and BMI z-scores develop-
ment lines.
There was an acceleration of mean weight z-scores at
six-seven years of age at all GMFCS levels according to
Figures 1,2 &3. Height z-score was the most deviant of
the three indices at all GMFCS levels. A steep fall in
height z-score with age was seen in GMFCS levels IV-V,
with more young children at start, in addition to the low-
est gross motor function level (Figure 6). The BMI z-
Table 2: The three children without complete anthropometric measurements before or 5 years after SDR operation
Boy, GMFCS IV Girl, GMFCS IV Boy, GMFCS IV
Gestational age, completed weeks: 38 28 30
Birth weight z-score -0.15 0.54 -0.81
Age at SDR operation, years 3.4 4.5 5.8
Weight z-score
First available measure 2.31 (pre SDR) -2.64 (1/2 year post SDR) -1.35 (pre SDR)
18 months post SDR 1.14 -2.94 -0.77
5 years post SDR 1.59 Follow-up declined -1.16
Height/length z-score
First available measure 1.53 (1/2 year post SDR) -3.37 (1/2 year post SDR) 0.04 (1 year post SDR)
18 months post SDR 0.71 -3.39 -0.70
5 years post SDR -0.55 Follow-up declined -0.74
BMI z-score
First available measure 2.15 (1/2 year post SDR) -0.40 (1/2 year post SDR) -1.21 (1 year post SDR)
18 months post SDR 0.92 -0.23 -0.47
5 years post SDR 2.20 Follow-up declined - 0.68Westbom et al. BMC Neurology 2010, 10:57
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score increased at GMFCS levels I-II from the earliest age
until ten years, when it levels off including measures from
a few children (Figure 7). At the other gross motor func-
tion levels the mean BMI z-score was more stable, located
above zero in GMFCS III (Figure 8) and below zero at
GMFCS IV-V (Figure 9).
Discussion
Design and reliability
This is, as far as we know, the first reported series of chil-
dren with CP of a specified subtype, longitudinally fol-
lowed with anthropometrics. The study was part of the
prospective follow-up during five years of a consecutive,
complete series of children with CP spastic diplegia with
gross motor function classified at all levels (GMFCS I-V),
who were operated with SDR during the first ten years at
Lund University Hospital. When introducing SDR in
1993 we chose this practice-based evidence approach to
evaluate the outcome [27,28]. The aim was to collect
feed-back data to improve our ability to choose the right
intervention for each child at the right time [29].
Table 3: Growth in SDR-operated children with CP sp diplegia
GMFCS I-II GMFCS III GMFCS IV-V TOTAL
n = 17 n = 15 n = 24 n = 56
Weight z-score median
(interquartile; range)
Preoperatively -1.48 (-2.09 to -1.11 -0.73 (-1.46 to -0.18; -1.63 (-1.97 to -0.70; -1.33 (-1.97 to -0.60;
-2.88 to 0.01) -3.84 to 0.61) -3.63 to 2.31) -3.84 to 2.31)
18 months post SDR -1.32 (-1.68 to -0.91; -1.21 (-1.67 to -0.24; -1.25 (-2.24 to -0.46; -1.27 (-1.97 to -0.50;
-2.48 to 0.10) -3.68 to 0.77) -4.13 to 1.29) -4.13 to 1.29)
5 years post SDR -0.64 (-1.85 to -0.25; -0.92 (-1.95 to 0.19; -1.10 (-1.73 to 0.20; -0.92 (-1.87 to 0.13;
-2.45 to 1.77) -3.02 to 1.87) -4.32 to 1.59) -4.32 to 1.87)
Pre-5 yrs postop, change 0.67 (-0.28 to 1.65; - 0.06 (-0.29 to 1.28; 0.29 (-0.34 to 1.30; 0.43 (-0.34 to 1.44;
-1.50 to 2.84)- 1.75 to 2.16)- 1.34 to 2.23)- 1.75 to 2.84)
Height/length z-score median
(interquartile; range)
Preoperatively -1.76 (-2.11 to -1.40; -2.08 (-2.80 to -1.52; -2.05 (-2.89 to -1.26; -1.92 (-2.6 to -1.25;
-3.25 to -0.56) -4.00 to 0.24) -3.64 to 0.59) -4.00 to 0.59)
18 months post SDR -1.81 (-2.35 to -1.04; -1.90 (-2.90 to -1.38; -1.75 (-2.63 to -1.04; -1.82 (-2.6 to -1.10;
-2.97 to -0.48) -3.94 to 0.21) -3.98 to 0.71) -3.98 to 0.71)
5 years post SDR -1.59 (-2.26 to -1.05; -1.81 (-2.67 to -1.38; -2.08 (-2.54 to -0.99; -1.77 (-2.42 to -1.07;
-2.89 to -0.41) -3.71 to 0.15) -3.93 to -0.49) -3.93 to 0.15)
Pre-5 yrs postop, change 0.19 (-0.05 to 0.47; 0.11 (-0.17 to 0.41; -0.19 (-0.58 to 0.26; 0.04 (-0.36 to 0.39;
-0.82 to 0.65)- 0.80 to 1.66)- 1.08 to 0.85)- 1.08 to 1.66)
BMI z-score median
(interquartile; range)
Preoperatively -0.57 (-0.92 to 0.02; 0.79 (-0.83 to 1.51; -0.30 (-1.30 to 0.41; -0.22 (-1.16 to 0.57;
-2.73 to 1.71) -2.82 to 2.51) -2.56 to 2.61) -2.82 to 2.61)
18 months post SDR -0.19 (-0.51 to 0.50; 0.87 (-0.60 to 1.20; -0.26 (-0.99 to 0.77; -0.17 (-0.85 to 0.90;
-2.12 to 1.34) -1.99 to 1.49) -2.90 to 3.00) -2.90 to 3.00)
5 years post SDR 0.38 (-0.72 to 1.53; 0.54 (-0.31 to 1.55; -0.14 (-0.64 to 1.62; 0.26 (-0.67 to 1.62;
-1.34 to 2.27) -2.67 to 3.41) -3.07 to 2.77) -3.07 to 3.41)
Pre-5 yrs postop, change 0.81 (0.16 to 1.92; - 0.23 (-0.39 to 1.44; 0.66 (-0.32 to 1.67; 0.57 (-0.32 to 1.79;
-2.43 to 3.19)- 1.86 to 2.08)- 1.93 to 3.56)- 2.43 to 3.56)
Anthropometric measurements in SDR-operated children with CP sp diplegia in different GMFCS levels, presented as z-scores, median 
(interquartile; range), of the reference population growth curves, and median change of weight, height and BMI z-scores during five yearsWestbom et al. BMC Neurology 2010, 10:57
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This series may be of value for comparison with other
series in the future, even though some of the children
were undernourished and/or had other health problems.
The presented pre-operative growth data are representa-
tive of the CP spastic diplegia subtype at the different
GMFCS levels in a developed society and a health care
setting with at least fairly good nutritional support,
including gastrostomy and available specialists in paedi-
atric gastrointestinal disorders and dieticians. Although
the spasticity reduction through SDR may have influ-
enced growth, the postoperative measurements indicate
existing growth potential in CP spastic diplegia.
The anthropometric data included in our follow-up
were the clinically used standard measurements of
Figure 1 Weight z-scores in GMFCS I-II. Weight z-score at different 
age in 17 children with CP spastic diplegia, GMFCS I-II. Their mean z-
score development with age is shown in black.
Figure 2 Weight z-scores in GMFCS III. Weight z-score at different 
age in 15 children with CP spastic diplegia, GMFCS III. Their mean z-
score development with age is shown in black.
Figure 3 Weight z-scores in GMFCS IV-V. Weight z-score at different 
age in 24 children with CP spastic diplegia, GMFCS IV-V. Their mean z-
score development with age is shown in black.
Figure 4 Height z-scores in GMFCS I-II. Height z-score at different 
age in 17 children with CP spastic diplegia, GMFCS I-II. Their mean z-
score development with age is shown in black.Westbom et al. BMC Neurology 2010, 10:57
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height/recumbent length and weight, the most precise
anthropometric measures in typically developing chil-
dren [30]. The reliability of weight measurements is high,
also in children with CP. In contrast, direct height/length
measurements were regarded as impossible to use in the
North American Growth in Cerebral Palsy Project
(AGCPP). Knee height was chosen as a proxy at func-
tional levels GMFCS III-V [3]. The children in our study
were without any significant scoliosis or severe joint con-
tractures [17]. The measuring was performed by two PTs
used to children with CP. The children were well
acquainted with the PTs and felt secure in the measuring
and training sessions. The PTs could keep the children
fully stretched, still and control that ankle, knee, hips and
back were in the right position in addition to right posi-
Figure 5 Height z-scores in GMFCS III. Height z-score at different 
age in 15 children with CP spastic diplegia, GMFCS III. Their mean z-
score development with age is shown in black.
Figure 6 Height z-scores in GMFCS IV-V. Height z-score at different 
age in 24 children with CP spastic diplegia, GMFCS IV-V. Their mean z-
score development with age is shown in black.
Figure 7 BMI z-scores in GMFCS I-II. BMI z-score at different age in 17 
children with CP spastic diplegia, GMFCS I-II. Their mean z-score devel-
opment with age is shown in black.
Figure 8 BMI z-scores in GMFCS III. BMI z-score at different age in 15 
children with CP spastic diplegia, GMFCS III. Their mean z-score devel-
opment with age is shown in black.Westbom et al. BMC Neurology 2010, 10:57
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tion of the heel and head. Therefore we regard the mea-
surements of stature as at least moderately reliable; at the
best functional levels GMFCS I-II highly reliable, similar
to the reference population.
As GMFCS and subtype-specific reference growth data
were unavailable, we chose the growth charts of typically
developing healthy children of the same age and gender
in our country as a reference, when describing the growth
of the study group. The reference population was > 3500
children born at term in 1973-75, i.e. before the "obesity
epidemic". They were followed by longitudinal measure-
m e n t s  f r o m  b i r t h  t o  l a t e  a d o l e s c e n c e  ( >  1 4  t i m e s  p e r
child) [21,22].
The computer-generated growth chart provided auto-
matic calculations of child age, z-score for every measure
and plotting without the common plotting errors of man-
ually completed growth charts [23]. The growth curves
were examined by a paediatrician (LW) for each child to
identify any errors in the measurements.
Gender
Twice as many boys as girls were selected for SDR, mainly
reflecting gender distribution of CP spastic diplegia in
our area (prevalence 1.3/1000 boys and 0.7/1000 girls)
[31]. Gender did not exhibit a significant effect on the
BMI change during the follow-up (p = 0.75).
Consequences of weight deviations in CP
Childhood obesity is an increasing problem all over the
world. It is associated with a higher chance of premature
death and disability in adulthood mainly due to cardio-
vascular disease, diabetes, cancer and osteoarthritis [32].
Increased obesity prevalence is reported in ambulatory
children with CP: from 7.7% in 1994-1997 to 16.5% in
2002-2004 [33], similar to that seen in the general paedi-
atric population [34].
Besides the above-mentioned association with severe
long-term health consequences, overweight may cause
activity limitations in CP. Simulated weight gain through
a heavy belt was shown to have an immediate negative
impact on energy costs of walking in children with CP
[35]. On the other hand, the NAGCPP study showed that
weight < -1 SD was associated with poor health and low
societal participation [3,36].
Stature
Several previous studies have shown that children with
CP are shorter and thinner than healthy children with
typical development of the same age [e.g. [2,16]]. The rel-
ative falling off in stature with age in children with severe
functional limitations (GMFCS levels IV-V) in this study
is consistent with previous reports [1,3,7,16]. The slight
catch-up of median height z-scores during the five years
of follow-up in children with standing and walking ability
(GMFCS levels I-III) in our study has not been described
previously (Table 1). This could be a chance finding.
When displayed as mean height z-scores at different ages,
no such increase is seen with age (Figures 4-5). The
growth potential in childhood CP is unknown, as all stud-
i e s  u p  t o  n o w  i n c l u d e  c h i l d r e n  w i t h  m a l n u t r i t i o n  a n d
other health problems.
BMI
Overweight and obesity are defined as abnormal or
excessive fat accumulation that may impair health. BMI
provides the most useful population-level measure of
overweight and obesity. At the individual level, however,
BMI should be considered only as a rough guide, because
it may not correspond to the same degree of fatness in
different individuals [32]. In children, the proportions of
muscle mass and fat mass may vary with age, and it is
conceivable that especially great variations may be seen
in children with CP, by age and functional level.
Overweight, obesity and SDR
Children in this series were SDR-operated early in life.
Their median weight and BMI z-scores increased with
age, and the prevalence of obesity increased from 4% at
median age 4.3 years to 15% five years later. If the spastic-
ity reduction after SDR promoted weight gain through
less energy requirement, it could be counteracted by
increased physical activity, hypothetically the case in the
GMFCS III children in this study, who reduced their
median BMI. According to Figures 2 and 8 the mean
weight and BMI z-scores increased again at six to seven
Figure 9 BMI z-scores in GMFCS IV-V. BMI z-score at different age in 
24 children with CP spastic diplegia, GMFCS IV-V. Their mean z-score 
development with age is shown in black.Westbom et al. BMC Neurology 2010, 10:57
http://www.biomedcentral.com/1471-2377/10/57
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years of age in GMFCS III. At this age all children in Swe-
den start school.
The accelerating mean weight z-scores at six-seven
years of age shown in this study for all GMFCS levels are
probably due to more physical inactivity in the school set-
ting than during the pre-school years, with much more
focus on activities in locomotion and mobility.
It is questionable whether the increased prevalence of
obesity should be viewed as a complication of the SDR
operation, as we do not know the "natural course" in non
SDR-operated children with spastic diplegia. Available
data are scarce, and include other CP subtypes. BMI > +2
SD was present in 6/106 children in Swedish children
with bilateral spastic CP (spastic tetraplegia and diplegia)
at mean age 7.1 years [16]. The prevalence of obesity,
defined as BMI over the 95th percentile, in ambulatory
children (mainly spastic hemiplegia and diplegia) with CP
was 14-16.5% according to anthropometric measures in a
US gait laboratory during 1998-2004 [33]. It is conceiv-
able that the prevalence of obesity accelerates after 5-6
years of age in children with CP as in other children [34].
Conclusions
The presented growth data for children with CP spastic
diplegia with different GMFCS levels are the first avail-
able subtype-specific data of value for comparison with
other series. As some of the children were undernour-
ished and/or had other health problems, the growth
potential is probably higher in optimal circumstances.
The children with spastic diplegia were all shorter than
the reference population. The median height z-score was
-1.92, and was unchanged after five years for the whole
group. There was a tendency towards an increasing stunt-
ing with age in severe gross motor dysfunction (GMFCS
levels IV-V) and the opposite, a slight catch-up of median
height in children with walking ability (GMFCS levels I-
III).
A significant increase in BMI z-scores was found dur-
ing five years of follow-up. For many children the weight
and BMI increase was highly desirable. The proportion of
children with underweight, thinness, decreased (n.s.),
while the prevalence of obesity increased (p < 0.05). The
question about increased weight gain velocity as a side
effect of SDR is unanswered at present. It may be that the
entire weight/BMI z-score increase with age was part of
the general "obesity epidemic".
Severe weight deviations in CP are common and should
be prevented to improve health, mobility, activity and
participation. Regular monitoring of weight and height or
proxy measures, entered into growth charts, and timely
interventions to promote healthy growth, are necessary.
These are the first available subtype- and GMFCS-spe-
cific growth data. The growth potential according to
these data should be regarded as a minimum. Until reli-
able GMFCS- and subtype-specific growth-charts from
adequately nourished and otherwise healthy children
with CP are available, we recommend the use of growth
data for typically developing children as a reference.
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